This trial will test if a pharmaceutical-grade cannabidiol called Epidiolex can help treat anxiety in children with epilepsy that hasn't responded well to other medications.
1 Primary · 0 Secondary · Reporting Duration: 16 weeks
20 Total Participants · 0 Treatment Group
Primary Treatment: Treatment · No Placebo Group · Phase 4
Age 6 - 17 · All Participants · 9 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: